The basic helix-loop-helix transcription factor, dHAND, is required for vascular development

Journal of Clinical Investigation

Volumn 105, Issue 3, 2000, Pages 261-270

  Yamagishi, Hiroyuki ^a,b   Olson, Eric N ^b   Srivastava, Deepak ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION REGULATION; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0033968447     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8856     Document Type: Article

References (50)

1. Folkman, J., and D'Amore, P.A. 1996. Blood vessel formation: what is its molecular basis? Cell. 87:1153-1155.
2. Risau, W., and Flamme, I. 1995. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11:73-91.
3. Risau, W. 1997. Mechanisms of angiogenesis. Nature. 386:671-674.
4. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science. 277:48-50.
5. Dumont, D.J., et al. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical in vasculogenesis of the embryo. Genes Dev. 8:1897-1909.
6. Sato, T.N., et al. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
7. Davis, S., et al. 1996. Isolation of angiopoietien-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169.
8. Suri, C., et al. 1996. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
9. Wang, H.U., Chen, Z., and Anderson, D.J. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:741-753.
10. Adams, R.H., et al. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13:295-306.
11. Dickson, M.C., et al. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 121:1845-1854.
12. Oshima, M., Oshima, H., and Taketo, M.M. 1996. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:297-302.
13. Chang, H., et al. 1999. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development. 126:1631-1642.
14. Yang, X., et al. 1999. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development. 126:1571-1580.
15. Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9-22.
16. Kim, K.J., et al. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:841-844.
17. Shalaby, E., et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:62-66.
18. Fong, G.H., Rossant, J., Gertsenstein, M., and Breitman, M.L. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:66-70.
19. Carmeliet, P., et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:435-439.
20. Ferrara, N., et al. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:439-442.
21. Dumont, D.J., et al. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 282:946-949.
22. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsburn, M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:735-745.
23. Takagi, S., Tsuj, T., Amagai, T., Takamatsu, T., and Fujisawa, H. 1987. Specific cell surface labels in the visual centers of xenopus laevis tadpole identified using monoclonal antibodies. Dev. Biol. 122:90-100.
24. He, Z., and Tessier-Lavigne, M. 1997. Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell. 90:739-751.
25. Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., and Fujisawa, H. 1995. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 121:4309-4318.
26. Kitsukawa, T., et al. 1997. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron. 19:995-1005.
27. Jan, Y.N., and Jan, L.Y. 1993. HLH proteins, fly neurogenesis, and vertebrate myogenesis. Cell. 75:827-830.
28. Olson, E.N., and Klein, W.H. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
29. Shivdasani, R.A., Mayer, E.L., Orkin, S.H. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 373:432-434.
30. Srivastava, D., Cserjesi, P., and Olson, E.N. 1995. A subclass of bHLH proteins required for cardiogenesis. Science. 70:1995-1999.
31. Srivastava, D., et al. 1997. Regulation of cardiac mesoderm and neural crest by the bHLH protein, dHAND. Nat. Genet. 16:154-160.
32. Thomas, T., Yamagishi, H., Overbeek, P.A., Olson, E.N., and Srivastava, D. 1998. The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. Dev. Biol. 196:228-236.
33. Schlaeger, T.M., Qin, Y., Fujiwara, Y., Magram, J., and Sato, T.N. 1995. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development. 121:1089-1098.
34. Li, L., Miano, J.M., Mercer, B., and Olson, E.N. 1996. Expression of the SM22 promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:1-11.
35. Baldwin, H.S., et al. 1994. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development. 120:2539-2553.
36. Iwama, A., et al. 1993. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem. Biophys. Res. Commun. 195:301-309.
37. Lin, Q., et al. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 125:4565-4574.
38. Maltepe, E., Schmidt, J.V., Baunoch, D., Bradfield, C.A., and Simon, C.M. 1997. Abnormal angiogenesis and response to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature. 386:403-407.
39. Pereira, F.A., Qiu, Y., Zhou, G., Tsai, M.J., and Tsai, S.V. 1999. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 13:1037-1049.
40. Solway, J., et al. 1995. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J. Biol. Chem. 270:13460-13469.
41. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. 1996. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195.
42. Li, L., Liu, Z.-C., Mercer, M., Overbeek, P., and Olson, E.N. 1997. Distinct serum response factor-mediated regulatory networks governing SM22 transcription in smooth, skeletal and cardiac muscle cells. Dev. Biol. 187:311-321.
43. Li, D.Y., et al. 1999. Defective angiogenesis in mice lacking endoglin. Science. 284:1534-1537.
44. Papadaki, M., Eskin, S.G. 1997. Effects of fluid shear stress on gene regulation of vascular cells. Biotechnol. Prog. 13:209-221.
45. Chapman, W.B. 1918. The effect of the heart-beat upon the development of the vascular system in the chick. Am. J. Anat. 23:175-203.
46. Kuo, C.T., et al. 1997. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11:2996-3006.
47. Tanaka, M., Chen, Z., Bartunkova, S., Yamasaki, N., and Izumo, S. 1999. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development. 126:1269-1280.
48. Lin, Q., Schwarz, J., Bucana, C., and Olson, E.N. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 276:1404-1407.
49. Molkentin, J.D., Black, B.L., Martin, J.F., and Olson, E.N. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1125-1136.
50. Yamagishi, H., Garg, V., Matsuoka, R., Thomas, T., and Srivastava, D. 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science. 283:1158-1161.